DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Short Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Short Term Provisions | ₹850 Cr | ₹527 Cr | ₹445 Cr | ₹1,265 Cr | ₹624 Cr |
What is the latest Short Term Provisions ratio of DIVIS LABORATORIES ?
| Year | Short Term Provisions |
|---|---|
| Mar2025 | ₹850 Cr |
| Mar2024 | ₹527 Cr |
| Mar2023 | ₹445 Cr |
| Mar2022 | ₹1,265 Cr |
| Mar2021 | ₹624 Cr |
How is Short Term Provisions of DIVIS LABORATORIES Trending?
| Years | Short Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹850 Cr | 61.29 | |
| Mar2024 | ₹527 Cr | 18.43 | |
| Mar2023 | ₹445 Cr | -64.81 | |
| Mar2022 | ₹1,265 Cr | 102.56 | |
| Mar2021 | ₹624 Cr | - | |
Compare Short Term Provisions of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹163,050.2 Cr | -5.8% | -1.6% | 10.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹401,541.0 Cr | -3.5% | -6.4% | -2.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹138,451.0 Cr | 1.4% | 7% | 23.7% | Stock Analytics | |
| CIPLA | ₹112,377.0 Cr | -4.7% | -6.8% | -0.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,355.5 Cr | -2.8% | -8.1% | -11.1% | Stock Analytics | |
| MANKIND PHARMA | ₹87,425.9 Cr | -1.1% | 3.3% | -13.4% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | -5.8% |
-1.6% |
10.9% |
| SENSEX | -0.4% |
-1.7% |
9.1% |
You may also like the below Video Courses